MEHMET OKCU to Middle Aged
This is a "connection" page, showing publications MEHMET OKCU has written about Middle Aged.
Connection Strength
0.128
-
Is Low-Dose Dextrose Prolotherapy as Effective as High-Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis? A Double-Blind, Ultrasound Guided, Randomized Controlled Study. Arch Phys Med Rehabil. 2023 02; 104(2):179-187.
Score: 0.051
-
Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res. 2004 Apr 15; 10(8):2618-25.
Score: 0.014
-
Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study. Nat Cancer. 2024 Apr; 5(4):590-600.
Score: 0.014
-
Preferences for survivorship education and delivery among Latino and non-Latino childhood cancer survivors and caregivers. J Cancer Surviv. 2025 Apr; 19(2):518-525.
Score: 0.014
-
BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol. 2015 Apr; 28(4):575-86.
Score: 0.007
-
Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro Oncol. 2012 Aug; 14(8):1018-25.
Score: 0.006
-
To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med. 2011 Nov; 13(11):948-55.
Score: 0.006
-
Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer. 2010 May 01; 116(9):2242-9.
Score: 0.005
-
Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol. 2009 Dec; 11(6):825-32.
Score: 0.005
-
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006 Apr 01; 24(10):1627-32.
Score: 0.004